CME Group is set to launch single-stock futures contracts for more than 50 leading US companies, with trading expected to commence on July 27, 2026, pending regulatory green light. The offering includes 55 standard contracts, each representing 100 shares, alongside 22 micro contracts that cover 10 shares apiece. This move marks a significant expansion of futures trading options on individual equities.
Details of the New Futures Contracts
The stocks selected for these contracts are top-tier names drawn from the S&P 500, Nasdaq-100, and Russell 1000 indexes, including giants like Apple, Nvidia, Tesla, Alphabet, Amazon, and Meta. Traders will be able to access these futures on CME’s Globex platform, which operates nearly 23 hours daily. This extended trading window allows participants to respond swiftly to overnight developments without waiting for the traditional market open.
Revival and Importance of Single-Stock Futures
Single-stock futures have been attempted before in the US market, notably through the OneChicago exchange in the early 2000s. However, earlier efforts faltered due to regulatory challenges and limited market interest. CME's recent announcement in February 2026 followed by this summer’s launch reflects a more calculated approach, driven by clear demand from institutional investors instead of speculative market creation. The availability of micro futures also lowers the threshold for entry, making it easier for smaller traders to participate without committing excessive capital.
Implications for Traders and Investors
For institutional players and savvy retail investors, these futures provide new avenues for managing risk and leveraging positions on individual stocks. The contracts allow control over large volumes of shares with lesser upfront investment thanks to use. also the introduction of micro contracts makes these strategies accessible at lower scale, for instance, a micro contract on a $200 stock equates to $2,000 in exposure. CME’s success with micro futures in equity index markets suggests this product could gain traction. It’s notable that no crypto assets are included in this rollout, keeping the focus purely on equities.
Final regulatory approval remains pending, and any adjustments to contract terms or margin requirements could still arise. The launch could reshape how investors engage with single-stock derivatives, adding liquidity and flexibility to their trading toolkit.
